MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

We retrospectively analyzed data from 197 patients with refractory or relapsed acute myeloid leukemia (r/rAML) who underwent allo‐HCT between January 2013 and February 2020 in our center (patients with promyelocytic leukemia were excluded). Of all patients, 86 achieved a complete morphological remis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Qi, Liu, Xinyue, Zhang, Yongping, Zhang, Dongmei, Li, Boran, Wang, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529132/
https://www.ncbi.nlm.nih.gov/pubmed/34432318
http://dx.doi.org/10.1002/jcla.23974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529132/
https://www.ncbi.nlm.nih.gov/pubmed/34432318
http://dx.doi.org/10.1002/jcla.23974

Ejemplares similares